Trials / Unknown
UnknownNCT02710786
Comorbidity After Gastric Bypass
Long-term Resolution of Comorbidites After Gastric Bypass
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25,000 (estimated)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate effect on comorbid disease and weight loss in the long-term (\>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.
Detailed description
Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Gastric bypass | Gastric bypass surgery, i.e., small gastric pouch and excluded main stomach |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2016-03-17
- Last updated
- 2023-12-26
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02710786. Inclusion in this directory is not an endorsement.